Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04589962 · ClinicalTrials.gov registry record
SUrgical Versus PERcutaneous AXillary Artery International Registry
A clinical trial, sponsored by IRCCS San Raffaele.
- Completed
- Registry status
- 700
- Enrollment target
NCT04589962: Completed study, sponsored by IRCCS San Raffaele.
NCT04589962 is a clinical trial that has completed, run by IRCCS San Raffaele. The registered enrollment target is 700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04589962 has completed, sponsored by IRCCS San Raffaele.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
The purpose of the Study is to compare the outcomes of the surgical and the percutaneous approach to the upper extremity access (axillary or brachial artery) during endovascular procedures on the aortic valve, the aorta, and its side branches.
Primary Outcome
Closure success rate of the procedure without any adjunctive procedures
Interventions
- OTHER access axillary or brachial artery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2020-10-09 |
| Est. Completion | 2022-02-28 |
What the finished NCT04589962 record still lists
NCT04589962 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which access axillary or brachial artery is the first listed.
NCT04589962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04589962 about?
NCT04589962 is a clinical study titled "SUrgical Versus PERcutaneous AXillary Artery International Registry". The purpose of the Study is to compare the outcomes of the surgical and the percutaneous approach to the upper extremity access (axillary or brachial artery) during endovascular procedures on the aortic valve, the aorta, and its side branches.
What is the current status of trial NCT04589962?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2020-10-09. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04589962?
The interventions under investigation include: access axillary or brachial artery (OTHER).
Who is sponsoring clinical trial NCT04589962?
This trial is sponsored by IRCCS San Raffaele, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI